Form D · Biotechnology
Aviceda Therapeutics, Inc.
Cambridge, MA · CIK 0001824762
Offering snapshot reported Jan 13, 2025 · SEC filing
- Reported sold
- $75M Offering amount: $207M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 17, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 17
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 13, 2025 | Amendment | $74,999,940 | No comparison | 17 | SEC filing |
| Nov 22, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| May 31, 2024 | Initial | $18,899,969 | No comparison | 18 | SEC filing |
| May 19, 2023 | Initial | $15,610,000 | No comparison | 11 | SEC filing |
| Mar 28, 2022 | Initial | $49,450,983 | No comparison | 11 | SEC filing |
| Mar 28, 2022 | Initial | $8,398,584 | No comparison | 16 | SEC filing |
| Aug 12, 2021 | Initial | $1,950,000 | No comparison | Not reported | SEC filing |
| Sep 16, 2020 | Initial | $4,250,000 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $5M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-530215
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Leerink Partners LLC | 39011 |
Source: Form D, filed Jan 13, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christoph Adams | Director |
| Kyrylo Bigay | Director, Executive |
| David Callanan | Executive |
| Ross Darwin | Director |
| Mohamed Genead | Director, Executive |
| Mariusz Gralewski | Director |
| David Guyer | Director |
| Tarek Hassan | Executive |
| Patrick Johnson | Director |
| Robert Kniaz | Director |
| Derek Kunimoto | Executive |
| Erin Lavelle | Director |
| Nancy Thomason | Director |
| Michael Tolentino | Director, Executive |
| Dmytro Voloshyn | Director |
| Paul Vukelic | Director |
| Jay Woods | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
One Broadway, 14 Th Floor
Cambridge, MA, 02142
Cambridge, MA, 02142